Neuronal Programmed Cell Death-1 Ligand Expression Regulates Retinal Ganglion Cell Number in Neonatal and Adult Mice

被引:14
|
作者
Sham, Caroline W. [2 ]
Chan, Ann M. [1 ]
Kwong, Jacky M. K. [1 ]
Caprioli, Joseph [1 ]
Nusinowitz, Steven [1 ]
Chen, Bryan [1 ]
Lee, Janice G. [1 ]
Gandhi, Nishant M. [1 ]
Francisco, Loise M. [3 ,4 ]
Sharpe, Arlene H. [3 ,4 ]
Chen, Ling [5 ]
Braun, Jonathan [2 ]
Gordon, Lynn K. [1 ,6 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China
[6] Greater Los Angeles Vet Affairs Healthcare Syst, Ophthalmol Sect, Los Angeles, CA USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
NERVE GROWTH-FACTOR; MOUSE RETINA; VERTEBRATE RETINA; IN-VIVO; RECEPTOR; PD-1; RESPONSES; SURVIVAL; DIFFERENTIATION; AP-2-ALPHA;
D O I
10.1097/WNO.0b013e3182589589
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: During mouse retina maturation, the final number of retinal ganglion cells (RGCs) is determined by highly regulated programmed cell death. Previous studies demonstrated that the immunoregulatory receptor programmed cell death-1 (PD-1) promotes developmental RGC death. To identify the functional signaling partner(s) for PD-1, we identified retinal expression of PD-1 ligands and examined the effect of PD-1 ligand expression on RGC number. We also explored the hypothesis that PD-1 signaling promotes the development of functional visual circuitry. Methods: Characterization of retinal and brain programmed cell death-1 ligand 1 (PD-L1) expression were examined by immunofluorescence on tissue sections. The contribution of PD-ligands, PD-L1, and programmed cell death-1 ligand 2 (PD-L2) to RGC number was examined in PD-ligand knockout mice lacking 1 or both ligands. Retinal architecture was assessed by spectral-domain optical coherence tomography, and retinal function was analyzed by electroretinography in wild-type and PD-L1/L2 double-deficient mice. Results: PD-L1 expression is found throughout the neonatal retina and persists in adult RGCs, bipolar interneurons, and Muller glia. In the absence of both PD-ligands, there is a significant numerical increase in RGCs (34% at postnatal day 2 [P2] and 18% in adult), as compared to wild type, and PD-ligands have redundant function in this process. Despite the increased RGC number, adult PD-L1/L2 double-knockout mice have normal retinal architecture and outer retina function. Conclusion: This study demonstrates that PD-L1 and PD-L2 together impact the final number of RGCs in adult mice and supports a novel role for active promotion of neuronal cell death through PD- 1 receptor-ligand engagement.
引用
收藏
页码:227 / 237
页数:11
相关论文
共 50 条
  • [41] Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
    Chen, Zhifang
    Pang, Nannan
    Du, Rong
    Zhu, Yuejie
    Fan, Lingling
    Cai, Donghui
    Ding, Yan
    Ding, Jianbing
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [42] Analysis of complement pathway in dacryoadenitis of programmed cell death-1 deficient mice
    Sakurai, Yutaka
    Ito, Masataka
    Karasawa, Yoko
    Takeuchi, Masaru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [43] Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
    Davies, Lindsay C.
    Heldring, Nina
    Kadri, Nadir
    Le Blanc, Katarina
    STEM CELLS, 2017, 35 (03) : 766 - 776
  • [44] Expression of programmed cell death protein 1 and programmed cell death ligand 1 in feline injection site fibrosarcomas
    Mikiewicz, Mateusz
    Pazdzior-Czapula, Katarzyna
    Fiedorowicz, Joanna
    Otrocka-Domaga, Iwona
    RESEARCH IN VETERINARY SCIENCE, 2024, 176
  • [45] Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance
    Asawapanumas, Thiti
    Tangnantachai, Nichthida
    Sukswai, Narittee
    Assanasen, Thammathorn
    Chanswangphuwana, Chantiya
    Lawsut, Panisinee
    Polprasert, Chantana
    Rojnuckarin, Ponlapat
    Bunworasate, Udomsak
    Wudhikarn, Kitsada
    ACTA HAEMATOLOGICA, 2022, 145 (05) : 542 - 552
  • [46] Discovery of phenyl-linked symmetric small molecules as inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
    Wu, Yizhe
    Zhang, Yu
    Guo, Yu
    Pan, Zhichao
    Zhong, Shichun
    Jin, Xinxin
    Zhuang, Weihao
    Chen, Sikang
    Gao, Jian
    Huang, Wenhai
    Dong, Xiaowu
    Che, Jinxin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [47] Programmed Cell Death Ligand 1 Expression in Canine Cancer
    Shosu, Kazuha
    Sakurai, Masashi
    Inoue, Kumi
    Nakagawa, Takayuki
    Sakai, Hiroki
    Morimoto, Masahiro
    Okuda, Masaru
    Noguchi, Shunsuke
    Mizuno, Takuya
    IN VIVO, 2016, 30 (03): : 195 - 204
  • [48] Clinical significance and therapeutic potential of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human colorectal cancer
    Grimm, M.
    Gasser, M.
    Koenigshausen, M.
    Stein, C.
    Lutz, J.
    Krol, S.
    Thiede, A.
    Heemann, U.
    Waaga-Gasser, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Prognostic implication of programmed cell death 1 protein and programmed cell death 1 ligand 1 expression in endometrial cancer
    Kim, J.
    Choi, J. H.
    Kong, J.
    Yang, W.
    Cho, H.
    Chay, D. B.
    Kim, J. H.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 47 - 47
  • [50] Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer
    Chatterjee, Jayanta
    Dai, Wei
    Abd Aziz, Nor Haslinda
    Teo, Pei Yun
    Wahba, John
    Phelps, David L.
    Maine, Christian J.
    Whilding, Lynsey M.
    Dina, Roberto
    Trevisan, Giorgia
    Flower, Kirsty J.
    George, Andrew J. T.
    Ghaem-Maghami, Sadaf
    CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3453 - 3460